OCT pioneer Fujimoto is 2017 Beckman-Argyros Vision Research Award winner
The Arnold and Mabel Beckman Foundation (Irvine, CA) has named James G. Fujimoto, Ph.D., the Elihu Thomson Professor of Electrical Engineering and Computer Science at the Massachusetts Institute of Technology (MIT; Cambridge, MA), as its 2017 Beckman-Argyros Vision Research Award winner. Fujimoto and MIT will receive $100,000 and $400,000, respectively, to further advance the application of optical coherence tomography (OCT).
Fujimoto pioneered OCT imaging in ophthalmology, now considered the standard of care with more than 30 million procedures performed worldwide every year. OCT can be combined with a range of instruments and Fujimoto is currently developing advanced optical imaging for cancer detection, including endoscopic OCT and surgical guidance.
Presented annually, the award recognizes an individual who has made and is continuing to make significant transformative breakthroughs in vision research, particularly through development of an innovative technology or fundamental scientific breakthrough that has been applied to, aided, and/or improved the vision sciences.
"This award will enable Dr. Fujimoto's lab to move beyond structural imaging of the eye to develop and demonstrate functional optical coherence tomography," explains Anne Hultgren, Beckman Foundation's executive director. "Functional imaging techniques can tell the doctor information about potential blood-flow issues or changes in cell function, and this is exciting because it can help provide early indicators of disease."
The proposed research will take a three-part approach and seeks to develop quantitative methods for imaging and measuring blood flow, identify surrogate markers for dark adaptation that can assess retinal function, and develop new technologies for high-speed, ultrahigh-resolution OCT.
For more information, please visit www.beckman-foundation.org.
BioOptics World Editors
We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)